Literature DB >> 28099830

Ribociclib for HR-Positive, Advanced Breast Cancer.

Gabriel N Hortobagyi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28099830     DOI： 10.1056/NEJMc1615255

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.

Authors:  Jason P W Carey; Cansu Karakas; Tuyen Bui; Xian Chen; Smruthi Vijayaraghavan; Yang Zhao; Jing Wang; Keith Mikule; Jennifer K Litton; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

Review 2.  Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 Inhibitors.

Authors:  Johannes Ettl
Journal:  Breast Care (Basel)       Date:  2019-03-28       Impact factor: 2.860

3.  Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review.

Authors:  Jennifer L Caswell-Jin; Sylvia K Plevritis; Lu Tian; Christopher J Cadham; Cong Xu; Natasha K Stout; George W Sledge; Jeanne S Mandelblatt; Allison W Kurian
Journal:  JNCI Cancer Spectr       Date:  2018-12-24

4.  Allostery governs Cdk2 activation and differential recognition of CDK inhibitors.

Authors:  Abir Majumdar; David J Burban; Joseph M Muretta; Andrew R Thompson; Tiffany A Engel; Damien M Rasmussen; Manu V Subrahmanian; Gianluigi Veglia; David D Thomas; Nicholas M Levinson
Journal:  Nat Chem Biol       Date:  2021-02-01       Impact factor: 15.040

5.  Complete Clinical Response in Locally Advanced Metastatic de novo Breast Cancer after Front-Line Treatment with Ribociclib/Letrozole within the RIBANNA Study.

Authors:  Christian Rudlowski; Nina Beermann; Lena Leitzen; Benno Nuding
Journal:  Breast Care (Basel)       Date:  2019-09-17       Impact factor: 2.860

6.  Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and Biomarkers.

Authors:  Nina Ditsch; Elmar Stickeler; Annika Behrens; Erik Belleville; Peter A Fasching; Tanja N Fehm; Andreas D Hartkopf; Christian Jackisch; Wolfgang Janni; Cornelia Kolberg-Liedtke; Hans-Christian Kolberg; Diana Lüftner; Michael P Lux; Volkmar Müller; Andreas Schneeweiss; Florian Schütz; Carla E Schulmeyer; Hans Tesch; Christoph Thomssen; Christoph Uleer; Michael Untch; Manfred Welslau; Achim Wöckel; Lena A Wurmthaler; Rachel Würstlein; Marc Thill; Bahriye Aktas
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-05-03       Impact factor: 2.915
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.